Lv1
40 积分 2022-11-22 加入
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
3个月前
已完结
Selection of positive controls and their impact on anti-drug antibody assay performance
4个月前
已完结
Non-specificity as the sticky problem in therapeutic antibody development
2年前
已完结
皖公网安备34019202002308
